Veritor Antigen Assay
Research payments
$8,794,795
Through program year 2024, $8,794,795 in research payments was reported against Veritor Antigen Assay, across 104 payments, paid by Becton, Dickinson and Company.
- Paid by
- Becton, Dickinson and Company
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $2,800 | 1 |
| 2023 | Research | $17,345 | 3 |
| 2022 | Research | $15,092 | 4 |
| 2021 | Research | $5,207,285 | 47 |
| 2020 | Research | $3,552,273 | 49 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jonathan Claud Lisle, IL Named on 5 payments
- Jeffrey Harris Greenville, SC Named on 5 payments
- Jeffrey Kingsley Columbus, GA Named on 5 payments
- Joseph Allen Vandalia, OH Named on 4 payments
- George Raad Charlotte, NC Named on 4 payments
- Brent Becker York, PA Named on 4 payments
- Luis Castillo Palm Springs, FL Named on 4 payments
- Robert Weaver Houston, TX Named on 4 payments
- Marc Mickiewicz Gallatin, TN Named on 4 payments
- Asa Oxner Tampa, FL Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.